These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19918325)

  • 1. Neuropathology of non-Alzheimer degenerative disorders.
    Dickson DW
    Int J Clin Exp Pathol; 2009 Aug; 3(1):1-23. PubMed ID: 19918325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of Neurodegenerative Diseases.
    Dugger BN; Dickson DW
    Cold Spring Harb Perspect Biol; 2017 Jul; 9(7):. PubMed ID: 28062563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia.
    Forrest SL; Shepherd CE; McCann H; Kwok JB; Halliday GM; Kril JJ
    Acta Neuropathol; 2021 May; 141(5):791-794. PubMed ID: 33744978
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular pathology of neurodegenerative disorders].
    Wakabayashi K
    Rinsho Shinkeigaku; 2013; 53(8):609-17. PubMed ID: 23965852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration.
    Li W; Li JY
    Transl Neurodegener; 2024 Mar; 13(1):16. PubMed ID: 38528629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.
    Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
    Hauw JJ; Hausser-Hauw C; Duyckaerts C
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathology of basal ganglia in neurodegenerative diseases].
    Wakabayashi K; Tanji K; Mori F
    Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.
    Kovacs GG; Milenkovic I; Wöhrer A; Höftberger R; Gelpi E; Haberler C; Hönigschnabl S; Reiner-Concin A; Heinzl H; Jungwirth S; Krampla W; Fischer P; Budka H
    Acta Neuropathol; 2013 Sep; 126(3):365-84. PubMed ID: 23900711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatamopathological spectrum of tauopathies.
    Revesz T; Holton JL
    Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
    Kawakami I; Arai T; Hasegawa M
    Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
    Gao J; Wang L; Yan T; Perry G; Wang X
    Mol Cell Neurosci; 2019 Oct; 100():103396. PubMed ID: 31445085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauopathies as clinicopathological entities.
    Irwin DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain.
    Wakabayashi K; Mori F; Tanji K; Orimo S; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):1-12. PubMed ID: 20532896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticobasal degeneration: selected developments.
    Lang AE
    Mov Disord; 2003 Sep; 18 Suppl 6():S51-6. PubMed ID: 14502656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Posttranslational Modifications to Disease Phenotype: A Substrate Selection Hypothesis in Neurodegenerative Diseases.
    Baskakov IV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
    Kwong LK; Uryu K; Trojanowski JQ; Lee VM
    Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.